ESLAW — ESTRELLA IMMUNOPHARMA INC
As of Q2 2026, 2 SEC-registered investment managers reported holding ESLAW (ESTRELLA IMMUNOPHARMA INC) in their latest 13F filings, with a combined reported value of $16.36K across 117.50K shares. That is +0.0% by share count (+0 shares) versus the previous quarter, while reported value moved +95.4%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
ESLAW is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| D. E. Shaw & Co history | Q2 2026 | 87.50K | $12.46K | 0.00% | Hold |
| Citigroup Inc history | Q2 2026 | 30.00K | $3.90K | 0.00% | Hold |
| UBS Group AG history | Q3 2025 | 1.28K | $67 | 0.00% | Reduce |
| Bank of America Corp history | Q2 2024 | 80 | $3 | 0.00% | New |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 4 funds)
| Fund | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D. E. Shaw & Co | 87.50K | 87.50K | 87.50K | 87.50K | 87.50K | 87.50K | 87.50K | 87.50K | 87.50K | 87.50K | 87.50K |
| Citigroup Inc | 30.00K | 30.00K | 30.00K | 30.00K | 30.00K | 30.00K | 30.00K | 30.00K | 30.00K | 30.00K | 30.00K |
| UBS Group AG | — | — | 5.09K | — | — | 4.45K | 1.33K | 1.28K | — | — | — |
| Bank of America Corp | — | — | 80 | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details